Search Results 441-450 of 24236 for In situ
... in situ hybridization (ISH) test 1. Part I Dose Escalation (CLOSED) Any solid tumor with * EGFR exon 20 insertion mutation * HER2 exon 20 insertion mutation
Patients treated for in situ carcinoma of the cervix who have completed curative therapy and are in remission for at least 12 months prior to signing the ...
Exceptions are colonic polyps, non-melanoma skin cancer or carcinoma in-situ of the cervix. Any of the following because this study involves an agent that ...
... in-situ of the cervix and prostate carcinoma ≤ Gleason Grade 6 with stable prostate specific antigen (PSA) levels; Subjects with plasma cell leukemia (PCL) ...
... in studies of treprostinil palmitil inhalation powderTPIP in ... - Interval malignancy with exception of completely treated in situ carcinoma of the
... situ within the last 5 years -Hospitalization for ... in elderly people with highly prevalent co-morbid conditions. ... This method requires no assumption of low ...
... in treating patients with HER2 expressing ductal carcinoma in situ. H2NVAC is a vaccine designed to stimulate specialized white blood cells in hopes of ...
History of another primary malignancy, with the exception of (i) curatively resected non-melanoma skin cancer, (ii) curatively treated in situ cervical ...
... in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer ... Adequately treated carcinoma in situ without evidence of disease (eg, cervical ...
LASIK is short for laser-assisted in situ keratomileusis. It is a surgery to correct blurry vision. The result of LASIK surgery for more than 99% of people ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.